Financial Performance - The company's operating revenue for Q1 2025 was ¥174,585,730.40, representing a 41.38% increase compared to ¥123,489,176.52 in the same period last year[5]. - The net loss attributable to shareholders for Q1 2025 was ¥38,684,856.37, which is a 40.85% increase in loss from ¥27,465,352.68 in the previous year[5]. - The weighted average return on equity was -2.13%, down from -1.46% in the previous year[5]. - The company's basic and diluted earnings per share were both -¥0.1138, a decrease of 40.84% from -¥0.0808 in the previous year[5]. - Total profit loss increased by 41.83% to -$38.68 million, mainly attributed to higher R&D costs[10]. - Net profit loss rose by 40.85% to -$38.68 million, driven by increased R&D expenditures[10]. - The company reported a total profit of -¥38,680,384.94, compared to -¥27,272,689.84 in the previous period, reflecting a decline of approximately 42.5%[20]. Cash Flow and Investments - The net cash flow from operating activities improved by 8.96%, amounting to -¥123,520,447.36 compared to -¥135,674,965.23 in the previous year[5]. - Cash inflow from investment activities decreased by 90.04% to $63.87 million, primarily due to reduced redemption of financial products[10]. - Cash outflow for investment activities decreased by 93.49% to $28.42 million, mainly due to lower investment payments[11]. - Cash flow from financing activities increased by 300% to $20 million, primarily due to new bank loans[11]. - The company received cash from investment income of $22.31 million, a 53.42% increase compared to the previous period[10]. - Investment activities generated a net cash inflow of ¥35,454,149.78, down from ¥204,402,861.79 in the previous period[23]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,317,013,204.68, a decrease of 6.23% from ¥2,471,026,433.23 at the end of the previous year[5]. - The total current assets decreased to RMB 1,067,566,490.09 from RMB 1,211,633,768.81, reflecting a decline of about 11.8%[16]. - The total liabilities decreased from RMB 635,648,000.55 to RMB 519,245,614.04, indicating a reduction of approximately 18.3%[17]. - The total non-current assets decreased to RMB 1,249,446,714.59 from RMB 1,259,392,664.42, reflecting a decline of approximately 0.8%[16]. - The total equity attributable to the parent company decreased to RMB 1,797,745,480.39 from RMB 1,835,356,327.68, indicating a reduction of about 2.0%[17]. - The total liabilities decreased by 30.15% in accounts payable, amounting to ¥232,299,009.55 from ¥332,559,669.82 in the previous year[9]. Operational Costs and Expenses - Total operating costs increased to ¥218,468,752.02 from ¥160,267,225.08, representing a growth of approximately 36.3%[20]. - Research and development expenses rose to ¥46,470,615.40, up from ¥37,852,197.88, marking an increase of about 22.5%[20]. - Operating profit decreased by 42.64% to -$38.58 million, primarily due to increased R&D expenses compared to the previous period[10]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 87,788[12]. - The largest shareholder, Shen Za, holds 8.12% of shares, with 9.36 million shares pledged[12].
中科金财(002657) - 2025 Q1 - 季度财报